Barbara Gayle Duncan Insider Trading $IMMU IMMUNOMEDICS INC
Get free email notifications about insider trading for Barbara Gayle Duncan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Barbara Gayle Duncan. Barbara Gayle Duncan is Director in IMMUNOMEDICS INC ($IMMU) and Director in Innoviva, Inc. ($THRX) and CEO in Euthymics Bioscience Inc ($DOVP) and Director in Euthymics Bioscience Inc ($DOVP) and President and CFO in Euthymics Bioscience Inc ($DOVP) and Director in MEDGENICS, INC. ($MDGN) and Chief Accounting Officer in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Chief Financial Officer in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in Atea Pharmaceuticals, Inc. ($AVIR) and Director in Adaptimmune Therapeutics PLC ($ADAP) and Director in Ovid Therapeutics Inc. ($OVID) and Director in Jounce Therapeutics, Inc. ($JNCE) and Director in Fusion Pharmaceuticals Inc. ($FUSN).
Barbara Gayle Duncan in IMMUNOMEDICS INC
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Barbara Gayle Duncan: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Oct 23 2020
$IMMU Market Capitalization: $442.84M
$IMMU Previous Close: $4.23
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Barbara Gayle Duncan in IMMUNOMEDICS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADAP, GNMX, AVIR, DOVP, FUSN, IMMU, THRX, ICPT, JNCE, OVID
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 23 2020 | IMMU | IMMUNOMEDICS INC | Duncan Barbara Gayle | Director | Option Exercise | D | 0.00 | 3,718 | 0 | 0 | |
| Oct 23 2020 | IMMU | IMMUNOMEDICS INC | Duncan Barbara Gayle | Director | Option Exercise | D | 0.00 | 6,540 | 0 | 0 | |
| Oct 23 2020 | IMMU | IMMUNOMEDICS INC | Duncan Barbara Gayle | Director | Sell | D | 0.00 | 49,244 | 0 | 0 | 49.2 K to 0 (-100.00 %) |
| Sep 15 2020 | IMMU | IMMUNOMEDICS INC | Duncan Barbara Gayle | Director | Option Exercise | M | 16.96 | 2,500 | 42,400 | 0 | |
| Sep 15 2020 | IMMU | IMMUNOMEDICS INC | Duncan Barbara Gayle | Director | Buy | M | 16.96 | 2,500 | 42,400 | 39,577 | 37.1 K to 39.6 K (+6.74 %) |
| Aug 20 2020 | IMMU | IMMUNOMEDICS INC | Duncan Barbara Gayle | Director | Option Exercise | M | 16.96 | 20,000 | 339,200 | 0 | |
| Aug 20 2020 | IMMU | IMMUNOMEDICS INC | Duncan Barbara Gayle | Director | Buy | M | 16.96 | 20,000 | 339,200 | 37,077 | 17.1 K to 37.1 K (+117.12 %) |
| Aug 14 2020 | IMMU | IMMUNOMEDICS INC | Duncan Barbara Gayle | Director | Option Exercise | M | 12.93 | 17,077 | 220,806 | 0 | |
| Aug 14 2020 | IMMU | IMMUNOMEDICS INC | Duncan Barbara Gayle | Director | Buy | M | 12.93 | 17,077 | 220,806 | 17,077 | 0 to 17.1 K |
| Jun 22 2020 | IMMU | IMMUNOMEDICS INC | Duncan Barbara Gayle | Director | Option Exercise | A | 33.62 | 6,540 | 219,875 | 6,540 | |
| Jun 22 2020 | IMMU | IMMUNOMEDICS INC | Duncan Barbara Gayle | Director | Grant | A | 0.00 | 3,718 | 0 | 13,385 | 9.7 K to 13.4 K (+38.46 %) |
| Jun 11 2019 | IMMU | IMMUNOMEDICS INC | Duncan Barbara Gayle | Director | Option Exercise | A | 12.93 | 17,077 | 220,806 | 17,077 | |
| Jun 11 2019 | IMMU | IMMUNOMEDICS INC | Duncan Barbara Gayle | Director | Grant | A | 0.00 | 9,667 | 0 | 9,667 | 0 to 9.7 K |
| Mar 07 2019 | IMMU | IMMUNOMEDICS INC | Duncan Barbara Gayle | Director | Option Exercise | A | 16.96 | 22,500 | 381,600 | 22,500 |
Page: 1